Skip Navigation

Cardiovascular Research 1999 44(1):5-9; doi:10.1016/S0008-6363(99)00211-4
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jalili, T.
Right arrow Articles by Walsh, R. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jalili, T.
Right arrow Articles by Walsh, R. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Signal transduction during cardiac hypertrophy: the role of G{alpha}q, PLC βI, and PKC

Thunder Jalili1, Yasuchika Takeishi and Richard A Walsh*

Department of Medicine, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106-5029, USA

* Corresponding author. Tel.: 1-216-844-3293; fax: 1-216-844-3145 raw19@po.cwru.edu

Received 6 November 1998; accepted 29 March 1999

The first 150 words of the full text of this article appear below.


    1 Introduction
 
Currently the precise biochemical pathogenesis of cardiac hypertrophy remains unclear. A great deal of investigation has been directed toward the examination of various signal transduction pathways that are thought to be involved in stimulating this process. In particular, the signaling pathways that use heterotrimeric G protein-coupled receptors have been the focus for many investigations. This review will focus on the function of the G{alpha}q family of proteins and its downstream effectors during cardiac hypertrophy. Hypertrophy is the final common pathway for a variety of insults to the normal cardiovascular system. Many mechanical and hormonal stimuli such as hypertension, valve disorders, and ischemic events, can produce a hypertrophic response. These pathologic stimuli cause an increase in the workload placed upon the heart resulting in hypertrophy and remodeling that has been observed at the myocyte [1] and the gross anatomical level. Current thought suggests that the hypertrophic response is a compensatory mechanism . . . [Full Text of this Article]


    2 G protein-coupled receptor signaling
 
2.1 The role of G{alpha}q signaling in cardiac hypertrophy
2.2 Signaling through G{alpha}q activates phospholipase c β (PLC β) and protein kinase C (PKC)
2.3 Protein kinase C and cardiac hypertrophy

    3 Conclusions
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
W. Soesanto, H.-y. Lin, E. Hu, S. Lefler, S. E. Litwin, S. Sena, E. D. Abel, J. D. Symons, and T. Jalili
Mammalian Target of Rapamycin Is a Critical Regulator of Cardiac Hypertrophy in Spontaneously Hypertensive Rats
Hypertension, December 1, 2009; 54(6): 1321 - 1327.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Asai, K. Okumura, R. Takahashi, H. Matsui, Y. Numaguchi, H. Murakami, R. Murakami, and T. Murohara
Combined therapy with PPAR{alpha} agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency
Cardiovasc Res, June 1, 2006; 70(3): 566 - 577.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Y. J. Kang
Cardiac Hypertrophy: A Risk Factor for QT-Prolongation and Cardiac Sudden Death
Toxicol Pathol, January 1, 2006; 34(1): 58 - 66.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Takahashi, K. Okumura, T. Asai, T. Hirai, H. Murakami, R. Murakami, Y. Numaguchi, H. Matsui, M. Ito, and T. Murohara
Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency
Cardiovasc Res, November 1, 2005; 68(2): 213 - 223.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Vijayan, E. L. Szotek, J. L. Martin, and A. M. Samarel
Protein kinase C-{alpha}-induced hypertrophy of neonatal rat ventricular myocytes
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2777 - H2789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. R. Dent, N. S. Dhalla, and P. S. Tappia
Phospholipase C gene expression, protein content, and activities in cardiac hypertrophy and heart failure due to volume overload
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H719 - H727.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. L. Hunton, L. Zou, Y. Pang, and R. B. Marchase
Adult rat cardiomyocytes exhibit capacitative calcium entry
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1124 - H1132.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Takahashi, K. Okumura, H. Matsui, Y. Saburi, H. Kamiya, K. Matsubara, T. Asai, M. Ito, and T. Murohara
Impact of {alpha}-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol
Cardiovasc Res, June 1, 2003; 58(3): 565 - 574.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. W. Cohen, D. S. Park, S. E. Woodman, T. M. Williams, M. Chandra, J. Shirani, A. Pereira de Souza, R. N. Kitsis, R. G. Russell, L. M. Weiss, et al.
Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts
Am J Physiol Cell Physiol, February 1, 2003; 284(2): C457 - C474.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Pang, D. L. Hunton, P. Bounelis, and R. B. Marchase
Hyperglycemia Inhibits Capacitative Calcium Entry and Hypertrophy in Neonatal Cardiomyocytes
Diabetes, December 1, 2002; 51(12): 3461 - 3467.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Xu, B. Jian, R. Chu, Z. Lu, Q. Li, J. Dunlop, S. Rosenzweig-Lipson, P. McGonigle, R. J. Levy, and B. Liang
Serotonin Mechanisms in Heart Valve Disease II: The 5-HT2 Receptor and Its Signaling Pathway in Aortic Valve Interstitial Cells
Am. J. Pathol., December 1, 2002; 161(6): 2209 - 2218.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. G. Pyle, M. C. Hart, J. A. Cooper, M. P. Sumandea, P. P. de Tombe, and R. J. Solaro
Actin Capping Protein: An Essential Element in Protein Kinase Signaling to the Myofilaments
Circ. Res., June 28, 2002; 90(12): 1299 - 1306.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Q. He and M. C. LaPointe
Src and Rac Mediate Endothelin-1 and Lysophosphatidic Acid Stimulation of the Human Brain Natriuretic Peptide Promoter
Hypertension, February 1, 2001; 37(2): 478 - 484.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Ruwhof and A. van der Laarse
Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways
Cardiovasc Res, July 1, 2000; 47(1): 23 - 37.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Matkovich and E. A. Woodcock
Ca2+-activated but Not G Protein-mediated Inositol Phosphate Responses in Rat Neonatal Cardiomyocytes Involve Inositol 1,4,5-Trisphosphate Generation
J. Biol. Chem., April 6, 2000; 275(15): 10845 - 10850.
[Abstract] [Full Text] [PDF]